Clinical and Experimental Obstetrics & Gynecology is a prominent journal published by IMR PRESS, dedicated to the fields of obstetrics, gynecology, and reproductive medicine. Since its establishment in 1974, this journal has been a crucial platform for the dissemination of research findings, innovative practices, and reviews that contribute to the advancement of women's health. With an Open Access model adopted in 2019, it ensures that high-quality research is accessible to all stakeholders in the field, thus promoting greater collaboration and knowledge sharing. Based in Hong Kong, the journal is indexed under various categories with a 2023 Quartile ranking of Q3 in Obstetrics and Gynecology and Q4 in Reproductive Medicine, affirming its role in shaping the academic conversation within these disciplines. Despite its current Scopus rankings placing it in the lower percentiles, the journal continues to grow in influence, making it an essential resource for researchers, healthcare professionals, and students aiming to stay at the forefront of clinical and experimental innovations in obstetrics and gynecology.

BJOG - An International Journal of Obstetrics and Gynaecology is a leading peer-reviewed journal in the field of obstetrics and gynecology, published by Wiley in the United Kingdom. With a rich history dating back to 1902, this esteemed journal is recognized for its significant contribution to advancing clinical practice and research, consistently ranking in the top tier (Q1) of its category, according to the 2023 Scopus rankings. Representing the best of 209 journals in the discipline, BJOG is dedicated to publishing high-quality research and innovative insights that address critical issues in women's health. While not an open-access journal, it provides valuable access options for institutions and individuals to stay informed about the latest developments and evidence-based practices. The journal's commitment to disseminating cutting-edge research makes it an essential resource for clinicians, researchers, and academics aiming to improve health outcomes in obstetrics and gynecology.

European Journal of Obstetrics & Gynecology and Reproductive Biology-X, published by ELSEVIER, serves as a pivotal platform in the fields of obstetrics, gynecology, and reproductive biology. With an ISSN of 2590-1613, this journal has developed a notable presence since its transition to Open Access in 2019, enabling wider dissemination of research findings and fostering collaboration across disciplines. Located in Amsterdam, Netherlands, this journal holds a commendable Q2 ranking in both Obstetrics and Gynecology and Reproductive Medicine categories for 2023, reflecting its impact and relevance in the scientific community. Researchers and practitioners can access cutting-edge studies and reviews, contributing to advancements in reproductive health and clinical practices. With a focus on innovative research and evidence-based practices, the European Journal of Obstetrics & Gynecology and Reproductive Biology-X is committed to bridging the gap between laboratory discoveries and the application in clinical settings, making it an essential resource for those dedicated to enhancing reproductive health outcomes.

Welcome to the European Journal of Obstetrics & Gynecology and Reproductive Biology, a premier publication dedicated to advancing the fields of obstetrics, gynecology, and reproductive medicine. Published by Elsevier, this journal has been a vital resource since its inception in 1971, continuing to provide high-quality, peer-reviewed research through 2024 and beyond. With an impressive impact factor and recognized in the Q2 quartile for both obstetrics and gynecology, as well as reproductive medicine, it ranks among the top journals in its field, being positioned at #59 out of 209 in Obstetrics and Gynecology and #29 out of 90 in Reproductive Medicine. Though not currently an Open Access journal, it remains committed to disseminating valuable findings to enhance clinical practice and facilitate further research. Researchers, professionals, and students can expect insightful articles, comprehensive reviews, and pioneering studies that significantly impact women's health and reproductive biology.

Gynecologie Obstetrique Fertilite & Senologie, published by ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, serves as a crucial resource for researchers and practitioners in the fields of obstetrics, gynecology, and reproductive medicine. Established in 2017 and continuing through 2024, this journal provides a platform for the dissemination of impactful research, evidenced by its placement in the Q3 category for both obstetrics and gynecology and reproductive medicine in 2023. Although it currently does not operate under an open-access model, the journal is committed to advancing knowledge and practice in women's health and reproductive issues, ensuring that professionals stay at the forefront of scientific developments. With an ISSN of 2468-7197 and an E-ISSN of 2468-7189, the journal not only supports the global medical community from its base in France but also contributes to the broader academic discourse on critical topics such as fertility and women's health. As researchers and professionals in the field seek to enhance their understanding and impact, Gynecologie Obstetrique Fertilite & Senologie remains an essential publication for quality research and innovative solutions in women’s health.

WOMEN'S HEALTH ISSUES, published by Elsevier Science Inc, stands as a premier journal within the realm of women’s health research, offering a vital platform for the dissemination of cutting-edge studies. As an influential publication with an impressive reputation, it encompasses critical areas such as social sciences, maternity and midwifery, obstetrics and gynecology, and public health. With a remarkable Q1 ranking across various categories in 2023, including Nursing, Maternity and Midwifery and Obstetrics and Gynecology, this journal is recognized for its substantial impact on advancing knowledge in women's health issues. Researchers and healthcare professionals will find valuable insights and empirical studies that inform practice and policy. Although the journal is not Open Access, it provides a wealth of information originating from rigorous research and expert reviews aimed at enhancing women’s health outcomes. To explore a comprehensive range of topics, this journal spans a convergence period from 1990 to 2024, continually evolving with the field's advancements.

Gynakologie is a specialized academic journal published by Springer Heidelberg, focusing on the dynamic field of obstetrics and gynecology. With an ISSN of 2731-7102 and an E-ISSN of 2731-7110, the journal aims to provide a platform for innovative research and discussions that contribute significantly to women's health. Launched in 2022 and set to converge by 2024, it has quickly established itself within the academic community, currently ranking in the Q4 category in Obstetrics and Gynecology as per the 2023 quartile assessments. Despite its current positioning, the journal is dedicated to enhancing visibility and scholarly impact in this essential medical field. Published in Germany, it plays an important role in disseminating valuable insights and findings among researchers, clinicians, and students alike, thus fostering a better understanding of women's health issues. While the journal currently lacks open access options, it remains committed to contributing to the body of knowledge and advancing practices that benefit patients worldwide.

CONTRACEPTION is a leading academic journal dedicated to advancing the field of reproductive health, published by Elsevier Science Inc. Since its inception in 1970, the journal has consistently provided a platform for high-quality research and insights in both Obstetrics and Gynecology and Reproductive Medicine, achieving notable recognition as a Q1 journal in these categories as of 2023. With an impact factor that underscores its significance—ranked #57 out of 209 in Obstetrics and Gynecology and #28 out of 90 in Reproductive Medicine according to Scopus—CONTRACEPTION is essential reading for researchers, clinicians, and students alike. The journal is committed to publishing innovative studies, review articles, and evidence-based guidelines that inform clinical practice and enhance patient care. Although it does not currently offer open access options, its comprehensive coverage of contemporary issues and empirical data makes it an invaluable resource for those invested in the future of reproductive healthcare.

Welcome to the Journal of Obstetrics and Gynaecology, a premier academic publication dedicated to advancing the field of obstetrics and gynecology. Published by Taylor & Francis Inc, this esteemed journal has been a vital resource since its inception in 1945, with a convergence period from 1980 to 2024. Now embracing the Open Access model since 2023, it aims to disseminate research more broadly, facilitating knowledge transfer among researchers, healthcare professionals, and students alike. With a current impact factor that situates it within the Q3 category of Obstetrics and Gynecology, the journal has garnered recognition as a significant contributor to the medical community, ranked #109 out of 209 in Scopus. Based in the United Kingdom, the journal focuses on publishing high-quality research that addresses contemporary issues in women's health, aiming to significantly enhance clinical practices and patient outcomes. Whether you are a seasoned researcher or a student venturing into the field, the Journal of Obstetrics and Gynaecology offers a wealth of knowledge, fostering innovation and excellence within this critical discipline.

ACTA Obstetricia et Gynecologica Scandinavica, published by Wiley, is a leading journal in the fields of obstetrics and gynecology, with its impressive history dating back to 1921. This esteemed journal holds a prestigious Q1 ranking in both Medicine (miscellaneous) and Obstetrics and Gynecology, positioning it in the top percentile of global research outputs according to Scopus. With an exceptionally high percentiles rank, #16 out of 209, it serves as a vital platform for researchers, practitioners, and students eager to contribute to and gain insights from cutting-edge studies impacting women's health. Although it does not currently provide open-access options, the journal’s rigorous peer-review process ensures that high-standard research reaches its diverse audience. By converging years of knowledge towards 2024, ACTA Obstetricia et Gynecologica Scandinavica continues to be essential in discussing contemporary issues and advancements in reproductive health, fostering significant scientific discourse and innovation.